US 9,623,091 B2
Factor IX polypeptides and methods of use thereof
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in

General

US 9,623,091 B2
Factor IX polypeptides and methods of use thereof
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Michael Szperka
Art Unit:
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
Agent:
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Inventors:
Glenn PIERCE; Samantha Truex; Robert T. Peters; Haiyan Jiang
Assignee:
BIOVERATIV THERAPEUTICS INC.
Priority:
07/09/10
Filed:
02/12/16
Granted:
04/18/17
Expiration:
07/09/30
Abstract
The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
Cooperative Patent Classification (CPC)
C12C12N9/644C12Y304/21022C12NC07K2317/21C07KA61K39/39533A61P7/04A61K

Analytics

Cases

Patent Assignments

Citations